Filing Details
- Accession Number:
- 0001600132-19-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-22 11:14:07
- Reporting Period:
- 2019-05-21
- Accepted Time:
- 2019-05-22 11:14:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600132 | Bellerophon Therapeutics Inc. | BLPH | Pharmaceutical Preparations (2834) | 473116175 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1641300 | Fabian Tenenbaum | 184 Liberty Corner Road Suite 302 Warren NJ 07059 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-21 | 5,000 | $0.60 | 484,282 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
